抗VEGF药物在眼科学与肿瘤学的应用研究进展
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

江西省自然科学基金资助项目(No.20181BAB205034); 江西省教育厅科学技术研究项目(No. GJJ170048)


Research progress of anti-neovascularization drugs in the relationship between ophthalmology and oncology
Author:
Affiliation:

Fund Project:

Jiangxi Natural Science Foundation(No.20181BAB205034); Science and Technology Research Project of Jiangxi Provincial Department of Education(No.GJJ170048)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    新生血管的形成是很多重要眼部疾病的共同病理改变,也是肿瘤生长、转移的基础。本文旨在介绍抗血管内皮生长因子(VEGF)药物在眼科学及肿瘤学领域的联系、应用及相关研究,提出了新的给药途径及目前面临的问题及挑战,以及抗VEGF药物在眼科应用中出现的益处与副作用,强调应该加强眼科医师与肿瘤科医师在基础、临床等方面的密切交流与合作。

    Abstract:

    The formation of neovascularization is not only the common pathological change of many important eye diseases, but also the basis of tumor growth and metastasis. this article introduced the relationship, application and related research of anti-angiogenic drugs in the field of ophthalmology and oncology, it also introduced the new ways of administration, facing problems and challenges now, as well as the benefits and side effects of neovascularization drugs in ophthalmology application. Through the discussion of this article, we should strengthen the communication and cooperation between ophthalmologists and oncologists in basic and clinical aspects.

    参考文献
    相似文献
    引证文献
引用本文

章爽,邵毅,高桂平.抗VEGF药物在眼科学与肿瘤学的应用研究进展.国际眼科杂志, 2020,20(10):1760-1763.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2019-11-19
  • 最后修改日期:2020-09-01
  • 录用日期:
  • 在线发布日期: 2020-09-17
  • 出版日期:
文章二维码